Trump Administration Seeks Delay in Louisiana Abortion Pill Lawsuit Review

Want the full story?
Read the complete article at KVIA
AI Summary
The Trump administration has requested a federal court to pause a lawsuit in Louisiana that aims to restrict access to abortion pills by mail. This request comes from the FDA as it conducts its own review of mifepristone, a key medication used in abortions. If granted, the administration will update the court within 14 days on any changes to regulations. The move has drawn criticism from anti-abortion groups, who feel frustrated by perceived delays in action against medication abortions. A hearing for the case is set for February 24, and the FDA had a deadline to respond to the lawsuit by Tuesday.
Key Details: • Hearing scheduled for February 24 regarding the lawsuit. • FDA must respond to the lawsuit by the deadline of Tuesday. • Trump administration to inform the court within 14 days of any regulatory changes.